In this matter, The Lancet’s digital health publishes a series entitled “Translating data in a pandemic” consisting of two series articles and one commentary. This series highlights the need to raise robustness standards for research conducted rapidly in a pandemic and improve data sharing systems for future outbreaks. But what challenges have existed since COVID-19 first broke out, and how likely are they to impact future epidemics like monkeypox?
Commentary by Lauren Gardner and colleagues highlights that pandemic models did not adequately inform responses to outbreaks and that projections were constrained by poor dissemination to policymakers and the public. For example, poor data reporting infrastructure in the US limited comparative analysis between states. The series paper by the same authors found that studies modeling COVID-19 were prone to misinterpretation and potentially harmful misuse. This problem was amplified as news outlets covered COVID-19 preprints extensively, expanding their reach far beyond the academic audience to include conspiracy theorists. The series paper also highlights systemic problems with the current information exchange systems in the United States. The authors question whether preprints or peer-reviewed journals are fit for purpose during a pandemic, as neither offer the required speed or quality for information sharing. The Lancet’s digital health advocates that models should not be used to make predictions for the public interest, but to provide experts with insight into disease epidemiology.

article information
publication history
ID
DOI: https://doi.org/10.1016/S2589-7500(22)00175-3
Copyright ©
© 2022 The author(s). Issued by Elsevier Ltd.
user license
Creative Commons Attribution (CC BY 4.0) |
ScienceDirect
Access this article on ScienceDirect
Linked Articles
- Real-time COVID-19 Prediction: Challenges and Opportunities of Model Performance and Translation
-
The COVID-19 pandemic pushed mathematical modeling into the spotlight as scientists rushed to use data to understand transmission patterns and disease severity, and to predict future outcomes of the epidemic. However, the use of COVID-19 modeling has been criticized, in part for some particularly flawed projections early in the pandemic.1 More than 2 years after the start of the pandemic, models continue to face serious obstacles as tools for informing the response to the outbreak.1 Population-level health outcomes are difficult to predict accurately, particularly cases and hospitalizations,2 as discussed in the International Institute of Forecasters blog.
-
full text
-
pdf
Open access
-
- An appraisal of prospective COVID-19 modeling studies in the United States: from the data to scientific translation
-
Infectious disease modeling can serve as a powerful situational awareness and decision support tool for policy makers. However, COVID-19 modeling efforts have faced many challenges, from poor data quality to changing policies and human behavior. In order to gain practical insights from the large body of available COVID-19 modeling literature, we provide a narrative overview using a systematic approach that quantitatively assesses prospective, data-driven modeling studies of COVID-19 in the United States. We analyzed 136 papers and focused on the aspects of models that are essential for decision makers.
-
full text
-
pdf
Open access
-
- Data collection and sharing in the COVID-19 pandemic: a cause for concern
-
Routine health care and research has been heavily influenced by digital health technologies. These technologies range from primary data collection in electronic health records (EHRs) and administrative claims to web-based, artificial intelligence-based analytics. The use of such health technologies has increased during the COVID-19 pandemic, in part due to the availability of this data. In some cases, this has resulted in profound and potentially long-lasting positive impacts on medical research and routine healthcare.
-
full text
-
pdf
Open access
-
- CODE-EHR Best practice framework for the use of structured electronic medical records in clinical research
-
Big data is important for new developments in global clinical science aimed at improving patients’ lives. Technological advances have led to the regular use of structured electronic health records, which have the potential to address important clinical evidence gaps that could improve patient care. The COVID-19 pandemic has demonstrated this potential in big data and related analytics, but it has also revealed important limitations. Data verification, data validation, privacy, and a public mandate to conduct research are key challenges to the effective use of routine health data.
-
full text
-
pdf
Open access
-